FDAnews
www.fdanews.com/articles/101090-fda-strengthens-warning-on-glaxo-8217-s-avandia

FDA Strengthens Warning on Glaxo’s Avandia

November 14, 2007

The U.S. Food and Drug Administration Wednesday toughened warnings on GlaxoSmithKline PLC’s diabetes drug Avandia, saying the product was linked to a potential increase in the risk of heart attacks.
The Wall Street Journal